Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 4/20 | 0.71 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.71 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9849965 | 1.00 | CHRNA7 (0.71) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| Hydrochloric Acid SCHEMBL6154466 | 0.98 | CHRNB2 (0.69) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| SCHEMBL16592137 | 0.79 | CHRNB2 (0.68) | CHRNA7CHRNB2CHRNA4ALDH1A1 | |
| SCHEMBL4681435 | 0.78 | CHRNB2 (0.45) | CHRNA7CHRNB2CHRNA4ALDH1A1 | |
| SCHEMBL9041158 | 0.75 | CHRNB2 (0.62) | CHRNA7CHRNB2CHRNA4ALDH1A1 | |
| SCHEMBL160708 | 0.67 | CHRNB2 (1.00) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| SCHEMBL13589890 | 0.67 | CHRNB2 (1.00) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| SCHEMBL21307962 | 0.67 | CHRNB2 (1.00) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| SCHEMBL29484643 | 0.67 | CHRNB2 (1.00) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 | |
| Fumaric Acid SCHEMBL29615612 | 0.64 | CHRNB2 (0.82) | CHRNA7CHRNB2CHRNA4ALDH1A1CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | BIOPOLIMERI S.R.L. (IT) | 2025-06-17 | — | — | US | claimed |
| US-20250186364-A1 | COMBINATION OF ANTISPASMODIC AND ANESTHETIC AGENTS FOR TOPICAL PRODUCTS AND THEIR METHOD OF USE | PRIMA INNOVATIONS, LLC | 2025-06-12 | — | — | US | claimed |
| EP-4362994-B1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S R L (IT) | 2025-03-12 | — | — | EP | claimed |
| EP-3703802-B9 | NASAL DELIVERY DEVICES AND METHODS OF USE THEREOF | CLEXIO BIOSCIENCES LTD (IL) | 2024-12-04 | — | — | EP | claimed |
| EP-3703802-B1 | NASAL DELIVERY DEVICES AND METHODS OF USE THEREOF | CLEXIO BIOSCIENCES LTD (IL) | 2024-10-16 | — | — | EP | claimed |
| US-20240293311-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | BIOPOLIMERI S.R.L. (IT) | 2024-09-05 | — | — | US | claimed |
| US-20240261464-A1 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | SAMYANG HOLDINGS CORPORATION (KR) | 2024-08-08 | — | — | US | claimed |
| EP-4374885-A1 | POWDER FORMULATION FOR TISSUE REPAIR, PREPARATION METHOD THEREFOR, AND INJECTABLE COMPOSITION FOR TISSUE REPAIR, COMPRISING SAME | Samyang Holdings Corporation (KR) | 2024-05-29 | — | — | EP | claimed |
| US-5663345-A | Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same | ENTROPIN, INC. (US) | 1997-09-02 | — | — | US | claimed |
| CN-1150802-A | Benzoylecgonine, ecgonine and ecgonidine derivatives | ENTROPIN INC (US) | 1997-05-28 | — | — | CN | claimed |
| EP-0765326-A1 | BENZOYLECGONINE, ECGONINE AND ECGONIDINE DERIVATIVES | ENTROPIN, INC. (US) | 1997-04-02 | — | — | EP | claimed |
| US-5559123-A | Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same | ENTROPIN, INC. (US) | 1996-09-24 | — | — | US | claimed |
| US-5525613-A | Covalently coupled benzoylecgonine ecgonine and ecgonidine | ENTROPIN, INC. (US) | 1996-06-11 | — | — | US | claimed |
| WO-1995034561-A1 | BENZOYLECGONINE, ECGONINE AND ECGONIDINE DERIVATIVES | ENTROPIN, INC. (US) | 1995-12-21 | — | — | WO | claimed |
| EP-0677051-A1 | DERIVATIVES OF BENZOYLECGONINE, ECGONINE AND ECGONIDINE AS MEDICINES | ENTROPIN, INC. (US) | 1995-10-18 | — | — | EP | claimed |
| US-5376667-A | Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties | ENTROPIN, INC. (US) | 1994-12-27 | — | — | US | claimed |
| CN-1095720-A | The benzoyl tropine carboxylic acid, their method of the derivative of tropine carboxylic acid and ecgonidine and preparation thereof and use | ENTROPIN INC (US) | 1994-11-30 | — | — | CN | claimed |
| WO-1994015935-A1 | DERIVATIVES OF BENZOYLECGONINE, ECGONINE AND ECGONIDINE AS MEDICINES | ENTROPIN, INC. (US) | 1994-07-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | CD44, HCAR3, HCAR2 | CHRNA7 1046/4885CHRNB2 1953/4885CHRNA4 1198/4885 |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | CES2, DAGLA, ACHE | CHRNA7 47/4885CHRNB2 50/4885CHRNA4 33/4885 |
| US-20240293311-A1 | CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS | CD44, HCAR3, HCAR2 | CHRNA7 1046/4885CHRNB2 1953/4885CHRNA4 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.